Louis Champel
Director/Board Member at VETOQUINOL SA
Louis Champel active positions
Companies | Position | Start | End |
---|---|---|---|
VETOQUINOL SA | Director/Board Member | 2010-09-21 | - |
Independent Dir/Board Member | 2009-08-26 | - |
Career history of Louis Champel
Former positions of Louis Champel
Companies | Position | Start | End |
---|---|---|---|
Lyon 3 Valorisation | Chief Executive Officer | 2001-12-31 | 2007-12-31 |
Merial SAS
Merial SAS Pharmaceuticals: MajorHealth Technology Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France. | Chief Executive Officer | 1996-12-31 | 1999-12-31 |
Chairman | 1996-12-31 | 1999-12-31 | |
Rhone Merieux
Rhone Merieux Chemicals: SpecialtyProcess Industries Part of Zoetis, Inc., Rhone Merieux manufactures pharmaceuticals, specialty, and agricultural chemicals. | Chief Executive Officer | - | - |
Training of Louis Champel
Sciences Po | Undergraduate Degree |
Statistics
International
France | 6 |
Operational
Chief Executive Officer | 3 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sectoral
Health Technology | 3 |
Process Industries | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
VETOQUINOL SA | Health Technology |
Private companies | 3 |
---|---|
Rhone Merieux
Rhone Merieux Chemicals: SpecialtyProcess Industries Part of Zoetis, Inc., Rhone Merieux manufactures pharmaceuticals, specialty, and agricultural chemicals. | Process Industries |
Merial SAS
Merial SAS Pharmaceuticals: MajorHealth Technology Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France. | Health Technology |
Lyon 3 Valorisation |
- Stock Market
- Insiders
- Louis Champel
- Experience